Gladstone opens institutes to study unsolved diseases

By The Science Advisory Board staff writers

May 8, 2020 -- Gladstone Institutes plans to launch two new biomedical research institutes in San Francisco to broaden its impact on unsolved diseases, including COVID-19.

Under the leadership of Dr. Melanie Ott, Gladstone Institute of Virology will study COVID-19 and study novel therapies against future infectious diseases. Researchers will focus on the way viruses interact with human host cells to cause disease and how to intervene in that process.

The other facility, which is a partnership between Gladstone and the University of California, San Francisco (UCSF), is the Gladstone-UCSF Institute of Genomic Immunology. Led by Dr. Alexander Marson, this facility will work to better understand the genetic control of human immune cells and develop novel cell-based immunotherapies.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.